Taiwan recalls 24 million tainted heart medicine tablets
Aug 02, 2018Business & FinanceComments Off on Taiwan recalls 24 million tainted heart medicine tablets
Taipei, Taiwan's Food and Drug Administration Thursday ordered a recall of 24.21 million tablets of heart medicine valsartan supplied by China's Zhuhai Rundu Pharmaceutical Co., Ltd. that have been found to be tainted.
The recall was instigated after it was discovered that the valsartan supplied by the Chinese company contained N-nitrosodimethylamine (NDMA), which is a potential carcinogen.
The four types of medicines affected are the Valsart F.C. Tab. 160mg, Valsart F.C.Tab. 80 mg, Asartan F.C. Tab. 5/80mg and the Valsart-H F.C. Tablets 80/12.5mg, produced by Taiwan's Standard Chem & Pharm C., Ltd.
The latest recall follows an earlier recall in July when more than 10 million tablets from six types of valsartan medicine supplied by another Chinese company, Zhejiang Huahai Pharmaceuticals were similarly tainted by NDMA.